atracurium has been researched along with Muscular Weakness in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvieux, CC; Gioux, M; Giroux-Metges, MA; Gueret, G; Morel, J; Pennec, JP; Rannou, F; Rossignol, B; Talarmin, H | 1 |
Blobner, M; Fink, H; Frick, CG; Helming, M; Martyn, JA | 1 |
Devlin, JW; Garpestad, E; Hill, NS | 1 |
Kopman, AF; Neuman, GG; Ng, J; Zank, LM | 1 |
Fry, RA; Yousif, HY | 1 |
David, WS; Davies, SF; Fluegel, WL; Iber, C; Leatherman, JW | 1 |
Coakley, J | 1 |
1 review(s) available for atracurium and Muscular Weakness
Article | Year |
---|---|
Should ICU patients receive muscle relaxants?
Topics: Atracurium; Critical Care; Humans; Intensive Care Units; Muscle Weakness; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 1996 |
1 trial(s) available for atracurium and Muscular Weakness
Article | Year |
---|---|
Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?
Topics: Adolescent; Adult; Aged; Androstanols; Anesthesia Recovery Period; Atracurium; Cholinesterase Inhibitors; Electric Stimulation; Female; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Neurons; Pain Measurement; Postoperative Complications; Rocuronium; Synaptic Transmission | 2004 |
5 other study(ies) available for atracurium and Muscular Weakness
Article | Year |
---|---|
Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat.
Topics: Animals; Atracurium; Chronic Disease; Disease Models, Animal; Female; Gene Expression; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle Strength; Muscle Weakness; Polyneuropathies; Rats; Rats, Wistar; Receptors, Cholinergic; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Systemic Inflammatory Response Syndrome | 2008 |
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic | 2010 |
Neuromuscular blockers and ARDS.
Topics: Atracurium; Double-Blind Method; Humans; Muscle Weakness; Neuromuscular Blocking Agents; Respiration, Artificial; Respiratory Distress Syndrome; Survival Rate; Time Factors | 2010 |
Anaesthesia for abdominal aneurysm repair in a patient with Guillain-Barré Syndrome.
Topics: Abdominal Pain; Aged; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Aortic Aneurysm, Abdominal; Atracurium; Desflurane; Fentanyl; Follow-Up Studies; Gait Disorders, Neurologic; Guillain-Barre Syndrome; Humans; Incidental Findings; Isoflurane; Male; Monitoring, Intraoperative; Muscle Weakness; Neuromuscular Nondepolarizing Agents; Piperidines; Propofol; Radiography, Abdominal; Remifentanil; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Muscle weakness in mechanically ventilated patients with severe asthma.
Topics: Acute Disease; Adolescent; Adult; Aged; Albuterol; Asthma; Atracurium; Bronchodilator Agents; Cohort Studies; Female; Glucocorticoids; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Muscle Weakness; Muscular Diseases; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Retrospective Studies; Risk Factors; Time Factors; Vecuronium Bromide | 1996 |